(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Stent: 2.25 x 28 mm xience prime, 3.0 x 18 mm xience prime.The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the lot number was not provided.The reported patient effect of angina is listed in the xience prime / xience prime small vessel (sv), and xience prime long length (ll), everolimus eluting coronary stent system (eecss), instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
It was reported that on (b)(6) 2014, the patient was admitted with chest pain.On (b)(6) 2014, a 3.0 x 33 mm xience prime stent was implanted in the proximal left anterior descending (lad) artery, a 2.25 x 28 mm xience prime stent was implanted in the distal left circumflex and a 3.0 x 18 mm xience prime stent was implanted in the proximal right coronary artery.The patient was discharged on (b)(6) 2014.On (b)(6) 2014 the patient was re-hospitalized with shortness of breath, chest pain and headache.Medications were administered and the patient was discharged home on (b)(6) 2014.On (b)(6) 2014 the patient was re-hospitalized with paroxysmal chest tightness and shortness of breath.Medications were administered and the patient was discharged home on (b)(6) 2014.On (b)(6) 2014 the patient was re-hospitalized due to paroxysmal chest tightness and shortness of breath.Medications were administered and the patient was discharged on (b)(6) 2014.On (b)(6) 2014 the patient was re-hospitalized with chest pain.Medications were administered and the patient was discharged home on (b)(6) 2014.No additional information was provided.
|